Cannabinoid Receptor 1 Signaling in Embryo Neurodevelopment

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 95, Issue 2, 2012, Pages 137-150

  Psychoyos, Delphine ^a   Vinod, K Yaragudri ^b,c   Cao, Jin ^a   Xie, Shan ^b   Hyson, Richard L ^d   Wlodarczyk, Bogdan ^e   He, Weimin ^a   Cooper, Thomas B ^b,c,f   Hungund, Basalingappa L ^b,f   Finnell, Richard H ^e  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f Columbia University ^*  (United States)

Author keywords

2 arachidonoylglycerol; Anandamide; CB1; Chick; Embryo; Endocannabinoid; Forebrain; G protein

Indexed keywords

ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; CANNABIS; FATTY ACID AMIDASE; LIPOPROTEIN LIPASE; PHOSPHATIDYLETHANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ANALYSIS; METABOLISM; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; CHICK EMBRYO; CHROMATOGRAPHY, LIQUID; EMBRYO, MAMMALIAN; ENDOCANNABINOIDS; ENDPOINT DETERMINATION; FEMALE; GLYCERIDES; MASS SPECTROMETRY; MICE; NEUROGENESIS; POLYUNSATURATED ALKAMIDES; PROSENCEPHALON; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

CANNABIS SATIVA;

EID: 84860242393     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20348     Document Type: Article

References (63)

1. Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzmán M, Galve-Roperh I 2005. The endocannabinoid system drives neural progenitor proliferation. FASEB J 19:1704-1706.
2. Anavi-Goffer S, Mulder J. 2009. The polarised life of the endocannabinoid system in CNS development. Chembiochem 10:1591-1598.
3. Applied Biosystems. 2003. Creating standard curves with genomic DNA or plasmid DNA templates for use in quantitative PCR. Applied Biosystems Available at: Accessed November 2010.
4. Balinsky BI. 1975. An introduction to embryology. New York. Saunders.
5. Berghuis P, Dobszay MB, Wang X, Spano S, Ledda F, Sousa KM, Schulte G, Ernfors P, Mackie K, Paratcha G, Hurd YL, Harkany T 2005. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci USA 102:19115-19120.
6. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urbán GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T 2007. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316:1212-1216.
7. Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernández-Ruiz JJ. 1999. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33:181-191.
8. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463-468.
9. Bromberg KD, Ma'ayan A, Neves SR, Iyengar R. 2008. Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth. Science 320:903-909.
10. Cadas H, di Tomaso E, Piomelli D. 1997. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoylphos- phatidylethanolamine, in rat brain. J Neurosci J 17:1226-1242.
11. Christiansen J, Coles E, Robinson V, Pasini A, Wilkinson DG. 2001. Screening from a subtracted embryonic chick hindbrain cDNA library: identification of genes expressed during hindbrain, midbrain and cranial neural crest development. Mech Dev 102:119-133.
12. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH 2001. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98:9371-9316.
13. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
14. Egertová M, Simon GM, Cravatt BF, Elphick MR. 2008. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules. J Comp Neurol 506:604-615.
15. ElSohly M. 2008. Quarterly report, Potency Monitoring Project, Report 100 [monograph on the internet]. NIDA. Available at Accessed November 27, 2011.
16. Eyal-Giladi H, Kochav S. 1976. From cleavage to primitive streak formation: a complementary normal table and a new look at the first stages of the development of the chick. I. General morphology. Dev Biol 49:321-337.
17. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW 1996. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:231-235.
18. Fernández-Ruiz JJ, Berrendero F, Hernández ML, Romero J, Ramos JA. 1999. Role of endocannabinoids in brain development. Life Sci 65:725-736.
19. Fride E, Gobshtis N, Dahan H, Weller A, Giuffrida A, Ben-Shabat S. 2009. The endocannabinoid system during development: emphasis on perinatal events and delayed effects. Vitam Horm 81:139-158.
20. Galve-Roperh I, Palazuelos J, Aguado T, Guzmán M. 2009. The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci 259:371-382.
21. Hamburger V, Hamilton HL. 1951. A series of normal stages in the development of chick embryo. J Morphol 88:49-92.
22. Harkany T, Guzmán M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K 2007. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28:83-92.
23. Harkany T, Keimpema E, Barabás K, Mulder J. 2008. Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol 286:S84-S90.
24. Howlett AC, Blume LC, Dalton GD. 2010. CB(1) cannabinoid receptors and their associated proteins. Curr Med Chem 17:1382-93.
25. Keegan J, Parva M, Finnegan M, Gerson A, Belden M. 2010. Addiction in pregnancy. J Addict Dis 29:175-191.
26. Keimpema E, Barabas K, Morozov YM, Tortoriello G, Torii M, Cameron G, Yanagawa Y, Watanabe M, Mackie K, Harkany T 2010. Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J Neurosci 30:13992-14007.
27. Makara JK, Mor M, Fegley D, Szabó SI, Kathuria S, Astarita G, Duranti A, Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D 2005. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci 8:1139-1141.
28. Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK 2006. Pharmacological characterization of novel water-soluble cannabinoids. Pharmacol Exp Ther 318:1230-1239.
29. Martínez de Ubago M, García-Oya I, Pérez-Pérez A, Canfrán-Duque A, Quintana-Portillo R, Rodríguez de Fonseca F, González-Yanes C, Sánchez-Margalet V 2009. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells. Biochim Biophys Acta 1791:740-745.
30. Mechoulam R, Hanus L, Martin BR. 1994. Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48:1537-1544.
31. Migliarini B, Carnevali O. 2009. A novel role for the endocannabinoid system during zebrafish development. Mol Cell Endocrinol 299:172-177.
32. Mulder J, Aguado T, Keimpema E, Barabás K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzmán M, Lu HC, Galve-Roperh I, Harkany T 2008. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA 105:8760-8765.
33. Mulder J, Zilberter M, Pasquaré SJ, Alpár A, Schulte G, Ferreira SG, Köfalvi A, Martín-Moreno AM, Keimpema E, Tanila H, Watanabe M, Mackie K, Hortobágyi T, de Ceballos ML, Harkany T 2011. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 134:1041-1060.
34. Nagy A, Gertsenstein M, Vintersten K, Behringer R. 2003. Manipulating the mouse embryo: a laboratory manual. 3rd ed. Cold Spring Harbor Laboratory: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA. pp. 31-140.
35. Newgreen DF, Howard MJ, Nishi R. 2009. Autonomic nervous system development. Encyclopedia of neuroscience. pp 837-848.
36. Paria BC, Dey SK. 2000. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 108:211-220.
37. Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, Bonner TI, Zimmer A, Dey SK 2001. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem 276:20523-20528.
38. Pertwee RG. 2008. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13:147-159.
39. Psychoyos D, Finnell R. 2008. Double whole mount in situ hybridization of early chick embryos. J Vis Exp 20:904. doi: 10.3791/904. Available at: Accessed November 2011.
40. Psychoyos D, Finnell R. 2009. Method for whole mount antibody staining in chick. J Vis Exp 24:956. doi: 10.3791/956. Available at: Accessed November 2011.
41. Psychoyos D, Stern CD. 1996a. Fates and migratory routes of primitive streak cells in the chick embryo. Development 122:1523-1534.
42. Psychoyos D, Stern CD. 1996b. Restoration of the organizer after radical ablation of Hensen's node and the anterior primitive streak in the chick embryo. Development 122:3263-3273.
43. Psychoyos D, Hungund B, Cooper T, Finnell RH. 2008. A cannabinoid analogue of Delta9-tetrahydrocannabinol disrupts neural development in chick. Birth Defects Res B Dev Reprod Toxicol 83:477-488.
44. 9-THC exposure. Open Neuropsychopharmacol J 2:64-76.
45. Rosenquist GC. 1966. An autoradiographic study of labelled grafts in the chick blastoderm. Development from primitive streak stages to stage 12. Contrib Embryol Carnegie Inst Wash 38:71-110.
46. Shea K, Geijsen N. 2007. Dissection of 6.5 dpc mouse embryos. J Vis Exp 2., doi: 10.3791/160. Available at: Accessed November 27, 2011.
47. Smith TH, Sim-Selley LJ, Selley DE. 2010. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? Br J Pharmacol 160:454-466.
48. Spratt NT. 1952. Localization of the prospective neural plate in the early chick blastoderm. J Exp Zool 120:109-130.
49. Stella N, Schweitzer P, Piomelli D. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
50. Stern CD. 2005. Neural induction: old problem, new findings, yet more questions. Development 132:2007-2021.
51. Substance Abuse and Mental Health Service Administration. 2002. Results from the 2001 National Household Survey on Drug Abuse NHSDA Series H-17. Rockville, MD: DHHS Publication No. SMA 02-3758.
52. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K 1995. 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
53. Sun YX, Tsuboi K, Okamoto Y, Tonai T, Murakami M, Kudo I, Ueda N. 2004. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem J 380:749-756.
54. Sun X, Dey SK. 2008. Aspects of endocannabinoid signaling in peri-implantation biology. Mol Cell Endocrinol 286:S3-S11.
55. Taylor AH, Amoako AA, Bambang K, Karasu T, Gebeh A, Lam PM, Marzcylo TH, Konje JC 2010. Endocannabinoids and pregnancy. Clin Chim Acta 411:921-930.
56. van Gelder MM, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N, National Birth Defects Prevention Study. 2008. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiol 20:60-66.
57. Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, Hungund BL 2005. Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 57:480-486.
58. Vitalis T, Lainé J, Simon A, Roland A, Leterrier C, Lenkei Z. 2008. The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. Eur J Neurosci 28:1705-1718.
59. Waddington CH. 1933. Induction by the primitive streak and its derivatives in the chick. J Exp Biol 10:38-46.
60. Waddington CH. 1936. Organizers in mammalian development. Nature 138:125.
61. Wilkinson DG. 1992. In situ hybridization: a practical approach, Oxford: IRL Press. pp. 75-83.
62. Wittler L, Kessel M. 2004. The acquisition of neural fate in the chick. Mech Dev 121:1031-1042.
63. World Health Organization. 1997. Cannabis: a health perspective and research agenda. Epidemiology of cannabis use [monograph on the internet]. Geneva: World Health Organization. Available at: Accessed December 2010.